Heron Therapeutics, Inc.HRTXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-11.54%
↑ 99% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-1499.17%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -11.54% | -229.4% |
| 2024 | -3.50% | +95.7% |
| 2023 | -81.70% | +50.2% |
| 2022 | -164.07% | +34.2% |
| 2021 | -249.29% | +0.7% |
| 2020 | -251.05% | -82.1% |
| 2019 | -137.86% | +38.8% |
| 2018 | -225.44% | +63.9% |
| 2017 | -624.10% | +95.3% |
| 2016 | -13243.16% | - |